Diagnosis and management of mantle cell lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance
Internal Medicine Journal · 2025-01 · 55 (1) · 117-129
DOI: 10.1111/imj.16561 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Internal Medicine Journal, online erschienen am 23.11.2024. Verfasst von Allison Barraclough und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology, Fiona Stanley Hospital, Perth, Western Australia, Australia. Hauptthemen laut MEDLINE: Lymphoma, Mantle-Cell, Disease Management. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 112 Literaturangaben.
Abstract (Originalsprache)
Mantle cell lymphoma (MCL) is a clinically heterogeneous B‐cell neoplasm with unique clinicopathological features, accounting for 5% of all non‐Hodgkin lymphoma. Although for many chemoimmunotherapy can lead to durable remissions, those with poor baseline prognostic factors, namely blastoid morphology, TP53 aberrancy and Ki67 >30%, will have less durable responses to conventional therapies. With this in mind, clinical trials have focused on novel targeted therapies to improve outcomes. This review details the recent advances in the understanding of MCL biology and outlines the recommended diagnostic strategies and evidence‐based approaches to treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Haematology, Fiona Stanley Hospital, Perth, Western Australia, Australia.
- Department of Haematology, Gosford Hospital, Gosford, New South Wales, Australia.
- School of Medicine and Public Health, The University of Newcastle, Newcastle, New South Wales, Australia.
- Department of Haematology, St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia.
- Department of Haematology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.
- Department of Haematology, Royal Perth Hospital, Perth, Western Australia, Australia.
ORCID-Profile: Allison Barraclough, Masa Lasica, Melita Cirillo, Matthew Ku
Zitieren
APA
Barraclough, A., Tang, C., Lasica, M., Smyth, E., Cirillo, M., Mutsando, H., Cheah, C. Y., & Ku, M. (2025). Diagnosis and management of mantle cell lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance. Internal Medicine Journal, 55(1), 117-129. https://doi.org/10.1111/imj.16561
Vancouver
Barraclough A, Tang C, Lasica M, Smyth E, Cirillo M, Mutsando H, et al. Diagnosis and management of mantle cell lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance. Internal Medicine Journal. 2025;55(1):117-129. doi:10.1111/imj.16561
BibTeX
@article{Barraclough2025,
author = {Barraclough, Allison and Tang, Catherine and Lasica, Masa and Smyth, Elizabeth and Cirillo, Melita and Mutsando, Howard and Cheah, Chan Y and Ku, Matthew},
title = {Diagnosis and management of mantle cell lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance},
journal = {Internal Medicine Journal},
year = {2025},
volume = {55},
number = {1},
pages = {117--129},
doi = {10.1111/imj.16561}
}
EUVIMED